 | • レポートコード：GIR-22F18331 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Powder Hemostatic Agent Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の粉末止血剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 粉末止血剤市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・吸収性止血剤、非吸収性止血剤 アプリケーション別セグメントは次のように区分されます。 ・病院、診療所、在宅医療 世界の粉末止血剤市場の主要な市場プレーヤーは以下のとおりです。 ・Johnson & Johnson（Ethicon）、Celox Medical、Amed Therapeutics、Cryolife、BioCer Entwicklungs-GmbH、Yunnan Baiyao、HHAO TECHNOLOGY 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、粉末止血剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な粉末止血剤メーカーの企業概要、2019年～2022年までの粉末止血剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な粉末止血剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別粉末止血剤の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの粉末止血剤のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での粉末止血剤市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および粉末止血剤の産業チェーンを掲載しています。 ・第13、14、15章では、粉末止血剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 粉末止血剤の概要 - タイプ別分析（2017年vs2021年vs2028年）：吸収性止血剤、非吸収性止血剤 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、診療所、在宅医療 - 世界の粉末止血剤市場規模・予測 - 世界の粉末止血剤生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Johnson & Johnson（Ethicon）、Celox Medical、Amed Therapeutics、Cryolife、BioCer Entwicklungs-GmbH、Yunnan Baiyao、HHAO TECHNOLOGY ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：吸収性止血剤、非吸収性止血剤 ・アプリケーション別分析2017年-2028年：病院、診療所、在宅医療 ・粉末止血剤の北米市場分析 - 粉末止血剤の北米市場：タイプ別市場規模2017年-2028年 - 粉末止血剤の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・粉末止血剤のヨーロッパ市場分析 - ：粉末止血剤のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：粉末止血剤のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・粉末止血剤のアジア太平洋市場分析 - 粉末止血剤のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 粉末止血剤のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・粉末止血剤の南米市場分析 - 粉末止血剤の南米市場：タイプ別市場規模2017年-2028年 - 粉末止血剤の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・粉末止血剤の中東・アフリカ市場分析 - 粉末止血剤の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 粉末止血剤の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Powder Hemostatic Agent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Powder Hemostatic Agent market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Powder Hemostatic Agent global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Absorbable Hemostatic Agent segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Powder Hemostatic Agent include Johnson & Johnson（Ethicon）, Celox Medical, Amed Therapeutics, Cryolife, and BioCer Entwicklungs-GmbH, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Powder Hemostatic Agent market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Absorbable Hemostatic Agent
Not Absorbable Hemostatic Agent
Market segment by Application can be divided into
Hospitals
Clinics
Home Care
The key market players for global Powder Hemostatic Agent market are listed below:
Johnson & Johnson（Ethicon）
Celox Medical
Amed Therapeutics
Cryolife
BioCer Entwicklungs-GmbH
Yunnan Baiyao
HHAO TECHNOLOGY
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Powder Hemostatic Agent product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Powder Hemostatic Agent, with price, sales, revenue and global market share of Powder Hemostatic Agent from 2019 to 2022.
Chapter 3, the Powder Hemostatic Agent competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Powder Hemostatic Agent breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Powder Hemostatic Agent market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Powder Hemostatic Agent.
Chapter 13, 14, and 15, to describe Powder Hemostatic Agent sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Powder Hemostatic Agent Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Powder Hemostatic Agent Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Absorbable Hemostatic Agent
1.2.3 Not Absorbable Hemostatic Agent
1.3 Market Analysis by Application
1.3.1 Overview: Global Powder Hemostatic Agent Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Global Powder Hemostatic Agent Market Size & Forecast
1.4.1 Global Powder Hemostatic Agent Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Powder Hemostatic Agent Sales in Volume (2017-2028)
1.4.3 Global Powder Hemostatic Agent Price (2017-2028)
1.5 Global Powder Hemostatic Agent Production Capacity Analysis
1.5.1 Global Powder Hemostatic Agent Total Production Capacity (2017-2028)
1.5.2 Global Powder Hemostatic Agent Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Powder Hemostatic Agent Market Drivers
1.6.2 Powder Hemostatic Agent Market Restraints
1.6.3 Powder Hemostatic Agent Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson（Ethicon）
2.1.1 Johnson & Johnson（Ethicon） Details
2.1.2 Johnson & Johnson（Ethicon） Major Business
2.1.3 Johnson & Johnson（Ethicon） Powder Hemostatic Agent Product and Services
2.1.4 Johnson & Johnson（Ethicon） Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Celox Medical
2.2.1 Celox Medical Details
2.2.2 Celox Medical Major Business
2.2.3 Celox Medical Powder Hemostatic Agent Product and Services
2.2.4 Celox Medical Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Amed Therapeutics
2.3.1 Amed Therapeutics Details
2.3.2 Amed Therapeutics Major Business
2.3.3 Amed Therapeutics Powder Hemostatic Agent Product and Services
2.3.4 Amed Therapeutics Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Cryolife
2.4.1 Cryolife Details
2.4.2 Cryolife Major Business
2.4.3 Cryolife Powder Hemostatic Agent Product and Services
2.4.4 Cryolife Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 BioCer Entwicklungs-GmbH
2.5.1 BioCer Entwicklungs-GmbH Details
2.5.2 BioCer Entwicklungs-GmbH Major Business
2.5.3 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Product and Services
2.5.4 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Yunnan Baiyao
2.6.1 Yunnan Baiyao Details
2.6.2 Yunnan Baiyao Major Business
2.6.3 Yunnan Baiyao Powder Hemostatic Agent Product and Services
2.6.4 Yunnan Baiyao Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 HHAO TECHNOLOGY
2.7.1 HHAO TECHNOLOGY Details
2.7.2 HHAO TECHNOLOGY Major Business
2.7.3 HHAO TECHNOLOGY Powder Hemostatic Agent Product and Services
2.7.4 HHAO TECHNOLOGY Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Powder Hemostatic Agent Breakdown Data by Manufacturer
3.1 Global Powder Hemostatic Agent Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Powder Hemostatic Agent Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Powder Hemostatic Agent
3.4 Market Concentration Rate
3.4.1 Top 3 Powder Hemostatic Agent Manufacturer Market Share in 2021
3.4.2 Top 6 Powder Hemostatic Agent Manufacturer Market Share in 2021
3.5 Global Powder Hemostatic Agent Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Powder Hemostatic Agent Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Powder Hemostatic Agent Market Size by Region
4.1.1 Global Powder Hemostatic Agent Sales in Volume by Region (2017-2028)
4.1.2 Global Powder Hemostatic Agent Revenue by Region (2017-2028)
4.2 North America Powder Hemostatic Agent Revenue (2017-2028)
4.3 Europe Powder Hemostatic Agent Revenue (2017-2028)
4.4 Asia-Pacific Powder Hemostatic Agent Revenue (2017-2028)
4.5 South America Powder Hemostatic Agent Revenue (2017-2028)
4.6 Middle East and Africa Powder Hemostatic Agent Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Powder Hemostatic Agent Sales in Volume by Type (2017-2028)
5.2 Global Powder Hemostatic Agent Revenue by Type (2017-2028)
5.3 Global Powder Hemostatic Agent Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Powder Hemostatic Agent Sales in Volume by Application (2017-2028)
6.2 Global Powder Hemostatic Agent Revenue by Application (2017-2028)
6.3 Global Powder Hemostatic Agent Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Powder Hemostatic Agent Sales by Type (2017-2028)
7.2 North America Powder Hemostatic Agent Sales by Application (2017-2028)
7.3 North America Powder Hemostatic Agent Market Size by Country
7.3.1 North America Powder Hemostatic Agent Sales in Volume by Country (2017-2028)
7.3.2 North America Powder Hemostatic Agent Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Powder Hemostatic Agent Sales by Type (2017-2028)
8.2 Europe Powder Hemostatic Agent Sales by Application (2017-2028)
8.3 Europe Powder Hemostatic Agent Market Size by Country
8.3.1 Europe Powder Hemostatic Agent Sales in Volume by Country (2017-2028)
8.3.2 Europe Powder Hemostatic Agent Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Powder Hemostatic Agent Sales by Type (2017-2028)
9.2 Asia-Pacific Powder Hemostatic Agent Sales by Application (2017-2028)
9.3 Asia-Pacific Powder Hemostatic Agent Market Size by Region
9.3.1 Asia-Pacific Powder Hemostatic Agent Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Powder Hemostatic Agent Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Powder Hemostatic Agent Sales by Type (2017-2028)
10.2 South America Powder Hemostatic Agent Sales by Application (2017-2028)
10.3 South America Powder Hemostatic Agent Market Size by Country
10.3.1 South America Powder Hemostatic Agent Sales in Volume by Country (2017-2028)
10.3.2 South America Powder Hemostatic Agent Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Powder Hemostatic Agent Sales by Type (2017-2028)
11.2 Middle East & Africa Powder Hemostatic Agent Sales by Application (2017-2028)
11.3 Middle East & Africa Powder Hemostatic Agent Market Size by Country
11.3.1 Middle East & Africa Powder Hemostatic Agent Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Powder Hemostatic Agent Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Powder Hemostatic Agent and Key Manufacturers
12.2 Manufacturing Costs Percentage of Powder Hemostatic Agent
12.3 Powder Hemostatic Agent Production Process
12.4 Powder Hemostatic Agent Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Powder Hemostatic Agent Typical Distributors
13.3 Powder Hemostatic Agent Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer